The FDA has approved a years-in-development treatment for multidrug-resistant HIV, a boon for those who've become resistant to most or all available HIV meds.
The Conference on Retroviruses and Opportunistic Infections (CROI), “the world’s preeminent scientific conference on HIV and related conditions,” takes place March 4-7 at the Hynes Convention Center in Boston, Massachusetts.